DRUG is currently covered by 5 analysts with an average price target of $139.8. This is a potential upside of $119.4 (585.29%) from yesterday's end of day stock price of $20.4.
DRUG's activity chart (see below) currently has 14 price targets and 22 ratings on display. The stock rating distribution of DRUG is 100% BUY.
Analysts' price targets on this stock were met 52% of the time, taking 187.6 days on average.
Highest price target for DRUG is $220, Lowest price target is $80, average price target is $139.8.
Most recent stock forecast was given by JOEL BEATTY from BAIRD on 03-Nov-2026. First documented stock forecast 25-Nov-2024.
Currently out of the existing stock ratings of DRUG, 13 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 25-Nov-2024
$107
$86.6 (424.51%)
$126
19 days ago
(03-Nov-2026)
2/5 (40%)
$85.45 (396.52%)
204
Buy Since 10-Jan-2025
$145
$124.6 (610.78%)
$145
3 months 3 days ago
(19-Aug-2026)
4/8 (50%)
$60.26 (71.11%)
208
Buy Since 08-Sep-2025
$147
$126.6 (620.59%)
$147
3 months 5 days ago
(17-Aug-2026)
1/5 (20%)
$67.52 (84.95%)
86
Buy Since 23-Jan-2025
$220
$199.6 (978.43%)
$93
6 months 2 days ago
(20-May-2026)
1/2 (50%)
$137.22 (165.76%)
327
Buy Since 21-May-2025
$80
$59.6 (292.16%)
$80
10 months 20 days ago
(02-Jan-2026)
2/2 (100%)
$-3.46 (-4.15%)
113
What is DRUG average time for price targets to be met?
Which analyst most recently updated their price target on DRUG?
Which analyst has the lowest performance score on DRUG with a proven track record?
Which analyst has the most public recommendations on DRUG?
Which analyst is the currently most bullish on DRUG?
Which analyst is the currently most reserved on DRUG?